临床资料 我院自1973年以来共收住本病30例,其中28例采用兰州(或武汉)的生物制品14～21针疗法,2例用上海生物制品研究所生产的疫苗5针疗法。于注射期间发病者24例,完成全疗程注射量以后2～28天起病者6例。发病方式多数是急性或亚急性,全组76.7％有不同程度前驱症状。脊髓型12例(其中2例呈Landry氏上升性麻痹),脑脊髓型3 Clinical data in our hospital since 1973, a total of 30 cases of this disease were admitted, of which 28 cases of Lanzhou (or Wuhan) biological products 14 to 21-pin therapy, 2 cases with the Shanghai Institute of Biological Products vaccine 5-needle therapy. During the injection of 24 cases of disease, the completion of the whole course of injection 2 to 28 days after onset in 6 cases. Most of the onset is acute or subacute, the whole group of 76.7% have varying degrees of prodromal symptoms. 12 cases of spinal cord type (including 2 cases of Landry’s ascending paralysis), cerebral spinal cord type 3